Download LCS Sample Newsletter Online Announcement

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Prostate-specific antigen wikipedia , lookup

Transcript
Lung Cancer Screening – Website/Newsletter Text
Your Facility Name is proud to be among the first hospitals in the area to introduce a
new lung cancer screening program and technology designed to offer health care
providers a faster pathway to lung cancer detection and treatment.
Like all cancers, the key to lung cancer survival is early detection. In 2011, the National
Lung Screening Trial (NLST) showed that screening with low-dose computed
tomography (CT) reduced lung cancer deaths among a population of heavy smokers
by 20 percent, when compared to using chest X-rays as the diagnostic tool.1
Your Facility Name has long been at the forefront of offering programs and cuttingedge technology for early detection of a wide range of conditions. The adoption of
DynaLync and DynaCAD Lung from Invivo Corporation provides critical tools to aid with
the identification, tracking, and management of relevant information to help the Your
Facility Name team reach a quick, definitive diagnosis.
Finding Lung Cancer in its Earliest Stages
Lung cancer is the leading cause of cancer death for both men and women, resulting
in more than 150,000 deaths each year in the United States; a figure that is greater than
the mortality rates of breast, prostate and colon cancer combined.2 Lung cancer
screening (LCS) using low-dose computed tomography (LDCT) has been clinicallyproven to reduce lung cancer mortality in individuals at high-risk for lung cancer.1
What is Low Dose CT Screening?
Low dose CT (LDCT) lung screening is quick and easy and results in a minimal amount of
radiation exposure. Your Facility Name is determined to raise awareness and improve
access to this testing for all people at high risk. Therefore, we are currently offering LDCT
lung screening to individuals who meet the established high-risk criteria.
Who is Eligible for Screening?
You may qualify for LDCT Lung Screening if you meet the following criteria:
You are between 55 and 77 years old
Have no signs or symptoms
Are currently a smoker or have quit within the past 15 years, and
Have smoked at least a pack of cigarettes a day for 30+ years
If you think you meet the criteria, please call 800.123.4567 between 8:00am and
4:00pm, Monday through Friday, to speak with our program coordinator to learn more
about our lung cancer screening program and services.
American Cancer Society. Cancer Facts & Figures 2014. Atlanta: American Cancer Society; 2014.
The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed
tomographic screening. N Engl J Med. 2011; 365:395-409.
1
2